GT Biopharma, Inc. has filed 864 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.
| Form | Date | Description |
|---|---|---|
| DEF 14A | 2026-07-02 | Proxy Statement |
| PRE 14A | 2026-06-18 | Preliminary Proxy Statement |
| 8-K | 2026-06-12 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits |
| 8-K | 2026-05-22 | Notice of Delisting or Transfer; Financial Statements and Exhibits |
| 10-Q | 2026-05-15 | Quarterly Report |
| 424B3 | 2026-05-13 | 424B3 |
| S-1 | 2026-04-30 | Registration Statement |
| 8-K | 2026-04-07 | Entry into a Material Definitive Agreement; Financial Statements and Exhibits |
| 10-Q/A | 2026-03-06 | Quarterly Report (Amended) |
| 10-Q/A | 2026-03-06 | Quarterly Report (Amended) |